Repetitive Transcranial Magnetic Stimulation as an Analgesic Treatment in Endometriosis Chronic Pain : Feasibility
Unknown statusNot applicableNCT03204682
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
Endometriosis is associated with different types of pain (acute, chronic, excess nociception, neuropathic) generated by different mechanisms in the nervous system. The rTMS could provide significant analgesia for refractory endometriosis pain. The aim of the study is to evaluate the feasibility of transcranial magnetic stimulation (rTMS) for analgesia on chronic refractory endometriosis pain.
Study details
- Official title
- Repetitive Transcranial Magnetic Stimulation as an Analgesic Treatment in Endometriosis Chronic Pain : Feasibility Study
- Conditions
- Deep Endometriosis
- Chronic Pelvic Pain
- Interventions
- Sponsor
- University Hospital, Clermont-Ferrand
- Start date
- 2016-04-13
- Primary completion
- 2018-04
- Sex
- Female
- Age range
- from 18 Years to 55 Years
- Results posted
- No results posted in this snapshot
- Countries
- France
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * Premenopausal (presence of at least one of the two ovaries and absence of clinical signs of menopause), * Not pregnant or breastfeeding; * At least one painful symptoms related to the existence of endometriosis (dyspareunia, dysmenorrhea, pain with defecation or urination, neuropathic pain); * Average VAS\> 4/10, at least 4 days out of 7 for at least 3 months; * Hormonal treatment failure continued in association or not for pain control; * A level of understanding and satisfying expression in French; * Monitoring possible during the duration of the study (4 weeks). * These patients should be affiliated to the French social security and should have signed a written consent after receiving clear information. Exclusion Criteria: * Prior treatment with rTMS, * Industrial accident or notion of litigation * Cons-indication for rTMS (cortical lesion within 2cm of the motor cortex, ECT treatment during previous month, epilepsy and / or a history of epilepsy, history of head trauma, intracranial hypertension; * Metal clip; pacemaker, * Pregnant or breastfeeding women; * Pain lasting less than 3 months; * Another pain more severe than that associated with endometriosis; * Lack of filling of the computerized questionnaires on Redcap; * Incapable of understanding about informed consent, * Patient under guardianship.
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT03204682